Breaking News

You are here » Indian-Commodity  :  Commodities  :  Turmeric High On Short Covering

12-May2011

Turmeric High On Short Covering

Turmeric increased high on limited covering. Information better arrivals, increased shares and lower foreign trade requirement had pressurised the costs of the product to drop at significantly decrease ranges. However, the expectation of exports increasing for the item in the upcoming weeks also guided the investors expand their situation

The agreement for May supply was exchanging at Rs 8,764.00, increase by 2.79% or Rs 238.00 from their prior ending of Rs 8,526.00. The available interest of deal was standing at 10255 lots.

The deal for June offering was transacting at Rs 8,406.00, upward by 1.03% or Rs 86.00 from their past ending of Rs 8,320.00. The available interest regarding settlement were standing at 7550 lots on NCDEX.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......